Insight into the Development of PET Radiopharmaceuticals for Oncology

While the development of positron emission tomography (PET) radiopharmaceuticals closely follows that of traditional drug development, there are several key considerations in the chemical and radiochemical synthesis, preclinical assessment, and clinical translation of PET radiotracers. As such, we o...

Full description

Saved in:
Bibliographic Details
Published inCancers Vol. 12; no. 5; p. 1312
Main Authors Lau, Joseph, Rousseau, Etienne, Kwon, Daniel, Lin, Kuo-Shyan, Bénard, François, Chen, Xiaoyuan
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 21.05.2020
Subjects
Online AccessGet full text

Cover

Loading…